Zymergi Logo
Cart
483Feb 18, 2022

483 Document: Cangene BioPharma, LLC dba Emergent BioSolutions

Sena G. Dissmeyer, FDA InvestigatorRobert J. Martin, FDA Investigator
FDANews 483 Cangene BioPharma, LLC dba Emergent BioSolutions Feb 18 2022 top
Sena G. Dissmeyer FDA Investigator Robert J. Martin FDA Investigator

On Feb 18, 2022, the FDA inspected Cangene BioPharma, LLC dba Emergent BioSolutions's Baltimore site. Explore the inspectional observations.